Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Cefatrizine→

Cefatrizine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
51627-14-6
Molecular formula
C18H18N6O5S2
Molecular weight
462.5 g/mol
Drug class
Oral cephalosporin beta-lactam antibacterial
Mechanism of action
Binds penicillin-binding proteins and inhibits bacterial cell-wall peptidoglycan cross-linking, producing bactericidal activity against susceptible organisms.
Indications / reported uses
  • Historically used for infections caused by cefatrizine-susceptible bacteria; current availability, approved indications and clinical role are jurisdiction-specific and should be checked against local product information

Sources: NLM MeSH — Cefatrizine · PubMed — Cefatrizine antibacterial pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Cefatrizine Environmental Risk Assessment (ERA) (the Cefatrizine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.